• Fluoxetine HCl: Bench Workflows for Serotonin Research

  2026-08-25

  This bench-focused guide shows how Fluoxetine HCl can connect serotonin transporter manipulation with 5-HT2C assays, reward behavior, neurogenesis and synaptic plasticity studies. It also explains why receptor potency, vehicle control and behavioral endpoint selection matter when translating cellular findings into depression research and stress resilience mechanisms.

• SIRT1/2 Inhibitor IV: Research Workflows

  2026-08-25

  SIRT1/2 Inhibitor IV (cambinol) enables mechanism-driven studies of dual SIRT1/SIRT2 inhibition across protein acetylation, lactate-linked signaling, cancer-cell apoptosis, and tumor growth. This guide translates the Ran lactylation findings into practical assay designs while emphasizing target-engagement controls, dosing optimization, and the limits of cross-model interpretation.

• PTPN2, STING–STAT3, and Autophagy in Psoriasis

  2026-08-24

  The reference study identifies PTPN2 as a psoriasis-relevant phosphatase that restrains a STING–STAT3 signaling axis and restores autophagy and apoptosis in keratinocytes. Using cellular experiments and an imiquimod-induced mouse model, the authors connect PTPN2 activity with reduced inflammatory cytokine production and attenuated psoriatic pathology, while highlighting rapamycin as a strategy that can enhance this response.

• Pollen Interference in EEM Bioaerosol Classification

  2026-08-24

  Zhang and colleagues developed a fluorescence-data workflow that reduces pollen interference when classifying hazardous biological substances. Combining spectral preprocessing, fast Fourier transform, and random forest classification increased reported accuracy to 89.24% across 31 sample types and enabled discrimination of several pathogenic or toxic targets.

• AO/PI Double Staining Kit: Practical Workflow

  2026-08-23

  The AO/PI Double Staining Kit provides a rapid fluorescent cell viability assay that separates green viable, orange apoptotic, and red necrotic signal patterns in one preparation. It is useful for microscopy-based cell health screening, but it should not be treated as a standalone mechanistic apoptosis assay or used without optimization when quantitative, automated, or non-fluorescent readouts are required.

• Difloxacin HCl: Applied Research Workflows

  2026-08-22

  Difloxacin HCl supports two distinct research paths: bacterial DNA gyrase inhibition for antimicrobial susceptibility testing and exploratory multidrug resistance reversal through MRP substrate sensitization. This practical guide connects assay setup, product handling, controls, and troubleshooting while clearly separating established evidence from hypothesis-generating applications.

• Fluoxetine HCl in Serotonergic Assays

  2026-08-22

  Fluoxetine HCl supports both acute 5-HT2C mechanism assays and chronic models of serotonergic adaptation, neurogenesis, and motivated behavior. This workflow separates transporter-driven signaling from downstream reward phenotypes, helping researchers design cleaner depression research and stress resilience experiments.

• Acetoacetic Acid Sodium Salt for Translational Research

  2026-08-21

  A mechanistic and strategic guide to using Acetoacetic acid sodium salt, or sodium 3-oxobutanoate, in energy metabolism research, diabetes metabolic imbalance studies, and translational assay development.

• Cy3 NHS Ester (Non-Sulfonated): Practical Guide

  2026-08-20

  Cy3 NHS ester (non-sulfonated) provides an orange fluorescent NHS ester for labeling accessible amino groups in proteins, peptides, and amine-functionalized oligonucleotides. It is appropriate for workflows that tolerate DMSO, DMF, or another compatible organic co-solvent, but not for strictly aqueous labeling or long-term storage of dye solutions.

• Epacadostat: Making IDO1 Biology Translational

  2026-08-20

  Epacadostat (INCB024360) offers a mechanistically precise way to interrogate IDO1-mediated immune suppression. This thought-leadership guide connects its nanomolar biochemical activity with standardized whole-blood immunometabolic workflows, combination strategy, translational decision-making, and the limitations that determine whether an IDO1 hypothesis is genuinely actionable.

• Phosbind Acrylamide: Practical SDS-PAGE Guide

  2026-08-19

  Phosbind Acrylamide is a phosphate-binding reagent for resolving phosphorylation-dependent protein mobility differences during SDS-PAGE without requiring phospho-specific antibodies. It is best suited to targets in the 30–130 kDa range and should be treated as a mobility-shift assay reagent, not as a phosphosite-mapping or universally validated phosphorylation quantification method.

• Cobalt Single-Atom Enzyme for NIR Multimodal Therapy

  2026-08-19

  This Nature Communications study develops a near-infrared-triggered cobalt single-atom enzyme anchored on hollow N-doped carbon spheres for integrated photodynamic, photocatalytic, and photothermal therapy. Its central contribution is a mechanistic strategy in which NIR-generated electrons and photothermal conversion amplify ROS effects while mild hyperthermia supports tumor damage and tissue-function preservation.

• L-Ornithine Workflows for Liver–Brain Research

  2026-08-18

  Use L-Ornithine to connect OTC activity, ammonia handling, and astrocyte metabolic responses in integrated liver–brain experiments. This practical guide translates recent realgar-toxicity findings into aqueous stock preparation, metabolic enzyme assay design, cell-model controls, and troubleshooting strategies.

• SMPD4, Ceramide, and Primary Cilia in Brain Development

  2026-08-18

  The 2024 Development study connects SMPD4-dependent ceramide production with primary cilium integrity, neural progenitor survival, and cerebellar development. By combining a mouse model with SMPD4-deficient human iPSCs, it provides a cross-species mechanistic framework for understanding microcephaly and cerebellar hypoplasia.

• TCAIM, OGDH, and Mitochondrial Metabolic Control

  2026-08-17

  A 2025 Molecular Cell study identifies TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds native OGDH and promotes its reduction through HSPA9 and LONP1. The work reveals a post-translational route by which mitochondrial proteostasis can regulate OGDH complex activity, carbohydrate catabolism, and broader metabolic state.

3589 records 1/240 page Next 12345 下5页 Last page